Prof. Dr. Muhammet Hulusi Satılmışoğlu

• ST Elevation Myocardial Infarction 3 publications
  Source: OpenAlex / PubMed MeSHView publications
• Coronary Artery Disease 2 publications
• Aortic Valve Stenosis 2 publications
• Ventricular Dysfunction, Left 2 publications

Medical areas of interest stated by the doctor on the institution profile. Source: medipol.com.tr.

Experience

• 2018 - 2023İstanbul Mehmet Akif Ersoy Göğüs Kalp ve Damar Cerrahisi Eğitim Araştırma Hastanesimedipol.com.tr
• 2010 - 2018İstanbul Mehmet Akif Ersoy Göğüs Kalp ve Damar Cerrahisi Eğitim Araştırma Hastanesimedipol.com.tr
• 2005 - 2006Yalova İl Sağlık Müdürlüğüİl Sağlık Müdürü
• 1999 - 2004Yalova İl Sağlık Müdürlüğüİl Sağlık Müdürü
• 1985 - 1987Gaziantep İl Sağlık Müdürlüğüİl Sağlık Müdürü Yardımcısı

Education

• 2010Abant İzzet Baysal Üniversitesi, Tıp Fakültesimedipol.com.tr
• 1984Çukurova Üniversitesi, Tıp Fakültesimedipol.com.tr

• SpecialtyCardiologymedipol.com.trFrom source
• InstitutionMedipol Esenler Üniversite Hastanesimedipol.com.trFrom source
• Area of workST Elevation Myocardial InfarctionExtracted from 3 publications · Model version —From source
• Publications57 publicationsOpenAlexFrom source
• Languagesİngilizcemedipol.com.trFrom source
• Last synchronised4 November 2026 20:27https://medipol.com.tr/doktorlarimiz/profdr-muhammet-hulusi-satilmisoglumedipol.com.tr

1. Long-Term Prognostic Value of Procalcitonin Level in Patients with Acute ST Segment Elevation Myocardial Infarction

   Kocaeli Medical Journal, 2022

   DOI 10.5505/ktd.2022.71235 Open-access full textSource: OpenAlex

2. Real-life data for major adverse cardiac events in patients with ST-elevation myocardial infarction prasugrel versus ticagrelor.

   PubMed, 2021

   DOI 10.26402/jpp.2021.4.08 PMID 34987130 2 citations (Europe PMC) Source: OpenAlex

3. Can biomarkers indicate the severity of coronary artery disease

   DOAJ (DOAJ: Directory of Open Access Journals), 2021

   DOI 10.17826/cumj.865009 1 citation (OpenAlex) Open-access full textSource: OpenAlex

4. The Importance Of Galectin 3 For Risk Stratification And Prognosis In Hypertrophic Cardiomyopathy

   EURAS Journal of Health, 2021

   DOI 10.17932/ejoh.2020.022/ejoh_v01i1002 Source: OpenAlex

5. Can Our Blood Groups Determine Our Life Expectancy?

   Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, 2021

   DOI 10.5222/bmj.2021.43534 Source: OpenAlex

6. Video-assisted thoracoscopic surgery for the treatment of pericardial hydatid cyst

   Acta chirurgica Belgica, 2018

   DOI 10.1080/00015458.2018.1523299 PMID 30280971 4 citations (Europe PMC) Source: OpenAlex

7. Relationship Between the Pleural Effusion and Mean Platelet Volume After Coronary Artery Bypass Graft

   Multidisciplinary Cardiovascular Annals, 2018

   DOI 10.5812/mca.3903 Source: OpenAlex

8. Assessment of long term prognostic value of admission vitamin D level in patients with acute STEMI undergoing primary percutaneous coronary intervention

   Dicle Medical Journal / Dicle Tip Dergisi, 2018

   DOI 10.5798/dicletip.497879 1 citation (OpenAlex) Open-access full textSource: OpenAlex

9. The importance of the neutrophil-to-lymphocyte ratio in patients with hypertrophic cardiomyopathy

   Revista Portuguesa de Cardiologia, 2017

   DOI 10.1016/j.repc.2016.09.014 PMID 28318851 26 citations (Europe PMC) Open-access full textSource: OpenAlex

10. Predictive values of D-dimer assay, GRACE scores and TIMI scores for adverse outcome in patients with non-ST-segment elevation myocardial infarction

    Therapeutics and Clinical Risk Management, 2017

    DOI 10.2147/tcrm.s124794 PMID 28408834 14 citations (Europe PMC) Open-access full textSource: OpenAlex